Filings
| Filing | Date | Type | Filed with |
|---|
| Exosens’ climate targets validated by the Science Based Targets initiative (SBTi) | Nov 5, 2026 | Operations update | Euronext |
|---|
| Monthly information on the total number of shares and voting rights in the share capital | Nov 2, 2026 | Monthly return | Euronext |
|---|
| Exosens delivers +23.5% revenue growth in Q3 2026, driven by stronger demand and faster-than-expected capacity ramp-up; Fully on track to meet upgraded 2026 outlook | Oct 27, 2026 | Guidance | Euronext |
|---|
| Exosens supports the accelerating deployment of next-generation nuclear technologies in the U.S. | Oct 8, 2026 | Operations update | Euronext |
|---|
| Monthly information on the total number of shares and voting rights in the share capital | Oct 1, 2026 | Monthly return | Euronext |
|---|
| Information mensuelle sur le nombre total d’actions et de droits de vote composant le capital social | Oct 1, 2026 | Monthly return | Euronext |
|---|
| Exosens relève ses objectifs pour l’exercice 2026, grâce à une montée en cadence plus rapide que prévu des capacités de production et à une forte dynamique commerciale | Sep 16, 2026 | Guidance | Euronext |
|---|
| Photonis Defense se voit attribuer une première commande pour le programme BiNOD de l’U.S. Army, marquant une étape clé dans le développement d’Exosens aux États-Unis | Aug 24, 2026 | Operations update | Euronext |
|---|
| Exosens announces the publication of its 2026 half-yearly financial report | Jul 27, 2026 | Interim report | Euronext |
|---|